Diabetes Care · 2007 · 61 citations · 28 references
MedicineEndocrinologyPharmacologyDiabetologyMetabolic RegulationPharmacodynamicsCardiovascular PharmacologyDiabetes MellitusHemodynamic PharmacologyInsulin ResistanceRenal HemodynamicsBlood FlowEndothelin Receptor AntagonistsEndothelin-mediated VasoconstrictionImpaired Insulin SensitivityInsulin Resistance TreatmentRenal Blood Flow MeasurementSplanchnic Blood Flow EffectsSplanchnic Perfusion
OBJECTIVE: Endothelin (ET)-1 is a vasoconstrictor and proinflammatory peptide that may inhibit glucose uptake. The objective of the study was to investigate if ET (selective ET(A) and dual ET(A)+ET(B)) receptor blockade improves insulin sensitivity in patients with insulin resistance and coronary artery disease. RESEARCH DESIGN AND METHODS: Seven patients (aged 58 +/- 2 years) with insulin resistance and coronary artery disease completed three hyperinsulinemic-euglycemic clamp protocols: a control clamp (saline infusion), during ET(A) receptor blockade (BQ123), and during combined ET(A) (BQ123) and ET(B) receptor blockade (BQ788). Splanchnic blood flow (SBF) and renal blood flow (RBF) were determined by infusions of cardiogreen and p-aminohippurate. RESULTS: Total-body glucose uptake (M) differed between the clamp protocols with the highest value in the BQ123+BQ788 clamp (P < 0.05). The M value corrected by insulin was higher in the BQ123+BQ788 than in the control clamp (P < 0.01) or the BQ123 clamp (P < 0.05). There was no difference between the control clamp and the BQ123 clamp. Mean arterial pressure did not change during the control clamp, whereas it decreased during both the BQ123 (P < 0.01) and BQ123+BQ788 (P < 0.05) clamps. RBF increased and renal vascular resistance decreased in the BQ123+BQ788 clamp (P < 0.05) but not in the BQ123 clamp. There was no change in SBF in either clamp. CONCLUSIONS: Dual ET(A)+ET(B) receptor blockade acutely enhances insulin sensitivity in patients with insulin resistance and coronary artery disease, indicating an important role for endogenous ET-1.
28
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Masashi Yanagisawa, Hiroki Kurihara, Sadao Kimura et al. · Nature · 1988 · 10.8K citations · Full text
Cloning and expression of a cDNA encoding an endothelin receptor
Hiroshi Arai, Seiji Hori, Ichiro Aramori et al. · Nature · 1990 · 2.6K citations
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
Takeshi Sakurai, Masashi Yanagisawa, Yoh Takuwat et al. · Nature · 1990 · 2.4K citations · Full text
Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
Cynthia J. Girman, Thomas Rhodes, Giel Nijpels et al. · Circulation · 2005 · 631 citations · Full text